PapersPMID:33713287
Effect of L-carnitine supplementation on renal anemia in patients on hemodialysis: a meta-analysis.
- findings
- 2
- compound
- 1
- endpoints
- 2
(R)-carnitine- Study, every finding
- meta-analysis
- Population, every finding
- Participants receiving hemodialysis; meta-analysis of 18 randomized trials (1090 participants), pooled across treatment durations and intervention routes
No finding here moved its endpoint.
What did not
How to read these marks →“However, the use of L-carnitine was not associated with a higher hemoglobin level (MD: 0.18, 95% CI -0.20 to 0.55; P = 0.35) and hematocrit level (MD: 1.07, 95% CI -0.73 to 2.87; P = 0.24).”
- Effect
- 0.18 mean difference, 95% CI −0.2 to 0.55
- No detected effect on haematocrit
very limited
- Effect
- 1.07 mean difference, 95% CI −0.73 to 2.87
Study record
- Design
- meta-analysis
- Species
- human
- Population
- patients with renal anemia receiving hemodialysis
- Participants
- 1,090
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 5